Last reviewed · How we verify
NCT05948124
Carnitine Supplementation in Pediatric Hemodialysis Patients
EARLY_PHASE1 trial testing L-carnitine in Carnitine Deficiency Due to Hemodialysis in 40 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | Ain Shams University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 August 2023 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 March 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- L-carnitine — full drug profile →
- isotonic saline — full drug profile →
Conditions studied
- Carnitine Deficiency Due to Hemodialysis — all drugs for Carnitine Deficiency Due to Hemodialysis →
Sponsor
Ain Shams University
Who can join
Under 16, any sex, with Carnitine Deficiency Due to Hemodialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is: 1. To determine the prevalence of carnitine deficiency among pediatric patients on hemodialysis. 2. To evaluate the efficiency of carnitine supplementation in children on regular hemodialysis with carnitine deficiency in the treatment of renal anemia, cardiac dysfunction, dyslipidemia, intradialytic muscle cramps and hypotension and their quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05948124
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of L-carnitine
Trials testing the same drug.
- NCT07437391 — Effect of L-Carnitine Supplementation in Preterm Neonates · NA · recruiting
- NCT06845046 — A Study to Improve Skeletal Muscle in Veterans With HIV · NA · recruiting
- NCT06960694 — Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis · Phase 2 · completed
- NCT06901323 — Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Child · Phase 4 · active not recruiting
- NCT05355311 — Enhancing the Effects of Alcohol Treatment With L-Carnitine · Phase 1 · completed
Other Ain Shams University trials
Trials by the same sponsor.
- NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
- NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
- NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05948124 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
- Last refreshed: 17 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05948124.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing